CRYOPROBES, ESPECIALLY FOR THE CRYOSURGERY OF DEEPLY LYING LESIONS

Abstract: The use of x-ray computer tomography permits the monitoring of ice-ball growth during cryosurgery. Thus the cryosurgery of deep-lying lesions and tumors becomes possible and the cryotherapy of tissue close to the body surface and/or in body cavities may be optimized. This monitoring technique is used in conjunction with special cryoprobes (5) designed to have an attenuation coefficient as close as possible to that of biological tissue. The cryoprobes (5) are constructed of low atomic number metals and/or plastics and can be used with liquid nitrogen or liquid noble gas, especially crypton and xenon. These techniques enable the use of long needle-shaped cryoprobes (5) with diameters of a few millimeters for the cryosurgery of deep-lying tumors.

Description: " 1 " Cryoprobes, Especially For The Cryosurgery Of Deeply Lying Lesions The present invention relates to improved cryoprobes, especially for the cryosurgery of deeply lying lesions and tumors, and to a method of monitoring the progress of a cryogenic freezing process. During the last twenty years, cryosurgery has become established as an important clinical technique. Many investigations have been carried out in a search ■for a better understanding of the process. The destruction of tissues by cooling to cryogenic temperatures is usually effected with a cryoprobe. This instrument has a continuously cooled tip, the cryotip, which is placed on or into the tissue to be destroyed. By way of background information, the state of the art in cryoprobe design will now be described briefly. Reviews of some of the most popular designs have been published elsewhere, for example, G.Gara y in "Cryosurgery", .edifced • by R.W. Rand et al., published in 1968 by C.C. Thomas in Springfield, U.S.A.; R.F. Barron in "Cryogenics in Surgery", edited by H. von Leden et al., published by Lewis in 197.1 in London, and D.E. Wild in "Practical Cryosurgery", l " edited by H.B. Holden and published by Pitmann 1975 in London. There are two main types of cryoprobes currently in use: a) high-pressure probes that use Joule-Tompson expansion to cool the tip; and OMPI b) liquid nitrogen probes which use the latent heat of boiling nitrogen to cool the tip. When used in the cryosurgery of deep lying tumors, it is essential to use a cryotip of small size, i.e. cryoprobes are required with very high cooling power. However, the cooling power of high pressure probes is- not as good as the cooling power of liquid nitrogen devices and only the latter are considered in the following. Liquid nitrogen cryoprobes cool by boiling liquid nitrogen within the cryotip. It is possible to maintain a tip temperature close to the boiling point n ' itrogen (-196 0 C at a pressure of one atmosphere) while extracting many watts of heat from the tissue. A typical liquid nitrogen system consists of: a) an appropriate vacuum storage flask for liquid nitrogen, b) transfer pipes and the associated valves, c) cryoprobe having a cryoti i.e. that part which contacts the tissue, and d) means of controlling the cryoprobe cooling power including a device for monitoring the cryotip temperature. Liquid nitrogen devices give rise to problems with regard to cryogenic storage transfer. The liquid is stored in the vacuum flask and its transfer to the cryoprobe is ideally through a flexible hose. The shaft of the cryoprobe usually has to be contained within an evacuated sheath to prevent the outer casing from becoming too cold and to reduce boiling of the liquid nitrogen. A few cryoprobe designs have solved the problem of liquid nitrogen transfer by incorporating a small storage dewar into the cryotip itself or by using the alternative technique of heating the transfer tubes to maintain the liquid in Leidenfrost flow. ~ 3 - The cryoprobe can conveniently be considered as a shaft portion and a tip portion, i.e. the cryotip. The shaft portion is essentially the coolant transfer tube.. In practice it consists of a outer sheath, vacuum insulated from the cold, internal tube. The internal tube is subdivided into the liquid nitrogen channel and the cold gas sink. For most applications in deep-in-body cryosurgery, the cryotip should be rigid. The cryotip is the part of the cryoprobe in which the liquid coolant is boiled off due to ' heat exchange with the tissue. During cryotherapy it should be placed directly into the tissue to be destroyed. A number of theoretical studies together with measurements of the growing ice mass have afforded a reasonable understanding of the thermal effects of the cryoprobes. Monitoring the volume of the deeply frozen tissue which will be destroyed during thawing is very important if cryosurgery is to be a precise and practical medical tool. However, no satisfactory technique has so far been developed for these purposes. Usually one observes optically the development of the "ice-ball". However, this method is limited to external cryosurgery applicatons, for example of the skin, and is highly imprecise. The aim of cryosurgery is to kill all cells within a well-defined region. Investigations on cell tissues frozen in vitro have indicated two main mechanisms of cell destruction, i.e. extra and intra-cellular ice formation. As the extra-cellular ice grows, cell water passes out of the cell which causes the cell to shrink. Lethal cell damage occurs on thawing due to the large uptake of water into the cell and eventual rupture. Several authors have published theoretical models to describe the frozen mass of tissue, the "ice-ball". When a cryotip is placed in contact with tissue and cooled a temperature gradient develops in the tissue, The tissue adjacent the probe will undergo a phase change and, as the cooling continues, the freezing front will propagate through the tissue. Eventually, a steady state will be reached where the rate at which heat is extracted by the cryoprobe b.alaπces the rate at which it is supplied by the tissue. Cryosurgery has primary and secondary applications to diseases of the brain and spiral cord. Foremost has been its use in the production of discreet, destructive, thalamic lesions in the surgical treatment of Parkinson's Disease and related disorders. Similarly, cryosurgery has been employed in the destruction of the normal pituitary gland, that is stereotactic-cryohypophysectomy, and in the treatment of selected cases of metastatic tumors. Cryosurgery is also useful in the management of difficult or unusual arterio-venous malformations of the brain and spinal cord and as a adjunct for other procedures, for example utilising the cryoprobe as a retractor in the micro-neurosurgical dissection of tumors and for the destruction of residual tumor tissues. Cryosurgery has been used in the treatment of selected cases of metastatic tumors on the surface and in body cavities. The cryotreatment of tumours deep inside the body has been prohibited by the lack of an appropriate monitoring technique. One of the main problems limiting the widespread use of cryosurgery is the difficulty of.controlling the amount of tissue that is destroyed during the treatment. It should be pointed out that cryoprobes are a highly flexible source of cooling. The rate of cooling can be easily and precisely regulated. It has however proved very difficult to monitor the propagation of the freezing front inside the body. The classical ice-ball monitoring techniques are simply not good enough. For the cryosurgery of surface lesions (warts, skin tumors etc.) the extent of cryodestruction is usually assessed by the extent of the white frozen area generated. This has several disadvantages, namely: the volume of tissue destroyed is somewhat less than the volume of tissue cooled below 0°C; the volume of tissue destroyed depends on the cooling speed which is difficult to assess from the extent of frost on the skin; the visual check is valid for two dimensions. The depth of deep frozen tissue can only be estimated by assuming a hemispherical ice-ball shape. Cryoprobes have been described that are combined with endoscopes for use in cryoprostectomy, more recently, which are small enough to be introduced into the bladder or the uterus. The most common method of monitoring ice-ball growth, other than direct visional palpation, is the use of thermocouples. They are usually mounted in hypodermic needles and are placed on the outer border of the lesion prior to cryosurgery; the freezing process is continued until the thermocouples register a temperature below zero. Practically, the usefulness of this technique depends on how accurately the thermocouples are placed. Accurate positioning can be quite difficult if the site is not accessible. Changes in tissue impedance and of the current flowing between an active and a reference electrode placed in the frozen region have been studied. These measurements are claimed to be superior to temperature measurements because they give information about the volume of the tissue destroyed, rather than just about the volume of the ice-ball. For example the low frequency impedance rises rapidly at the eutectic point due to extracellular ice formation. However, these measurements give information only about the volume and not the shape of the ice-ball. Although measurements of the cryoprobe tip temperature have been shown to be unreliable as an indication of ice-ball size, it has been suggested that a heat flux measurement can be used. However, this can be used only for the initial stages of freeze. From this brief description it can be seen that the techniques appropriate for the precise monitoring, let alone imaging of the ice-ball development are missing. Furthermore, all the classical techniques are applicable only to the cryosurgery of tissue close to the body surface. It is a principle object of the present invention to provide an improved method of monitoring the growth of the ice-ball during cryosurgery, preferably by the use of three-dimensional imaging techniques, and, for this purpose, to provide an improved cryoprobe which makes the use of such improved imaging techniques practicable. Furthermore the present invention is also intended to make it possible for cryosurgery to be carried out at locations deep inside the body while still enabling monitoring of the cryosurgical operation. For these purposes the invention is also concerned with the provision of a cryoprobe of reduced size and adequate cooling power, which is constructed so as to allow the use of the monitoring technique proposed herein. According to the present invention, there is provided a cryoprobe comprising a shaft portion and a cryortip wherein at least the cryotip consist? of a material or materials of low atomic number Z.O.5. The invention is based on the recognition that by employing a cryotip of low atomic number it will be possible to use modern methods of medical imaging for example, x-ray computer tomography, to provide a three dimensional image of the ice-ball development and indeed without the imag-e being significantly impaired by artifacts. This method offers the further advantage that the diseasedtissue, for example the tumor, the position of the cryotip and the temperature distribution around the cryotip can all be visualised at the same time. The absorption of x-rays(E=80 keV) in biological tissues is mainly due to Compton scattering. Thus, it is proportional to he .tissue density. Using computer tomography, a density variation of a few parts per thousand can be detected. Manufacturers of CT scanners have chosen to relate attenuation specifically to water and air using a scale designed to produce a range of positive and negative integers for the materials of clinical interest, namely so-called Hausenfeld units (HU). For example, a change of density of 1% means a change of 10 HU. Water is the main component of almost all biological tissues, for example over 90 % of both blood and muscular tissue. In the temperature range of interest, i.e. from the typical body temperature of 36.6 C down to the eutectic point of the intracellular fluid, ca. -21 C, the changes of density of water are rather large. For example, the density of water is 0.9935 g/cc at 36.6 C and 0.9999 g/cc at 0°C. The difference in density, about 0 . 6% , is detectable with CT systems. At the freezing point the density of ice is 0.9168 g/cc, i.e. the change in density due to the change in phase is 8.3?ό or 83 HU. Thus, the invention is based on the realisation that computer tomography will give an image of the propagation of the freezing front and some indication of the temperature gradients involved. The inventor has proved this experimentally by in vitro studies which show that the development of the ice-ball can be easily imaged using computer tomography. Studies have been made of many tissues of biological origin; cerebrospinal fluid, blood, animal fats, meat, white and grey brain matter. These results show that the change in density due to freezing is easily detectable by computer tomography and much higher than the natural variation of density in the tissues studied. Furthermore, the data derived to date suggest that, as expected, the largest part of the density change is due to phase change. The spatial resolution of modern CT installations is ca. 2 to 3 mm and the "slice thickness" is a few millimeters. The minimum time for reconstruction is a few seconds per slice. Thus, both the spatial and temporal resolutions of available CT systems are appropriate for imaging the growth of the ice- ball during cryosurgery. Real time imaging should permit feedback optimisation of cryosurgery procedures, Furthermore, cryosurgery of even the deepest internal organs becomes possible. As previously mentioned, the invention proposed the use of a cryotip of a material of low atomic number Z 15. The material will, for practical reasons, normally be metal* and indeed one of the group comprising lithium, beryllium, magnesium and aluminium or an allo' of any of these elements, either with themselves or with other elements. In a particularly 'practical embodiment, the cryotip consists of an inner heat exchanger and a thin outer shell. The heat exchanger conveniently consists of a sintered metal. In this arrangement the shell is made of aluminium or another metal of low atomic number. n arrangements of this kind the outer shell is conveniently covered with a layer of noble metal, copper or chromium, having a thickness less than 0.5 mm and preferably less than 0.2 mm. This arrangement is not only relatively easy to manufacture but it also avoids corrosion of the outer shell and possible danger to the patient through the use of, for example, beryllium. The aforementioned layer covering the outer shell is conveniently applied by plating. In an arrangement of the above-mentioned kind, the shaft portion preferably has a smaller cross-section than the cryotip. This arrangement is beneficial because it means that the shaft portion is less noticable in the image produced by computer tomography. In other words, the danger of creating artifacts is reduced,particularly at radiographically .unfavourable angles of the cryoprobe which may be necessary in practice. The use of a shaft portion with a smaller cross-section than the cryotip is favourable in cases of deep-in-body surgery. In practice the invention envisages a cryoprobe in which the cryotip has a cross-sectional area smaller than 20 square mm and preferably smaller than 10 square mm. The cryotip will be preferably used with a shaft portion having a cross sectional area below 20 square mm. The cryotip is preferably egg-shaped with a relatively pointed front end which facilitates the introduction into body tissue for deep-in-body surger ." The pointed head allows the tissues to be pushed aside without being severed so that the damage caused to the body by the introduction of the cryotip is minimal. As a shaft in any case has a smaller diameter than the cryotip, the presence of the shaft is not objectionable. One particularly advantageous arrangement, which can also be used with conventional cryoprobes, comprises the use as a coolant of one of liquefied nitrogen at a pressure greater than two atmospheres, a liquefied noble gas, or a mixture of a liquefied noble gas with another cryocoolant. In one particularly advantageous arrangement the liquefied noble gas is helium kept in superfluid state i.e. below 2.15 K. An especially beneficial arrangement comprises the use of crypton or xenon or a mixture of these gases as the liquefied noble gas. This arrangement is particularly beneficial with a cryoprobe of small dimensions,in accordance with the present teaching, because it can be transferredthrough the relatively narrow shaft portion to the cryotip without suffering an undue pressure loss and can develop the maximum cooling power in the cryotip for a given size thereof. A further problem which is encountere with existing cryoprobes, and which becomes more critical as the shaft portion is made smaller in cross-section, is the problem of preventing outside of the shaft portion becoming ./cool. In the case ' of deep-in-body cryosurgery, this cooling may cause damage of the tissue surrounding the shaft portion. Conventional cryoprobes use a vacuum jacket to prevent the cooling of the outside of the shaft portion. The use of a vacuum jacket becomes however increasingly difficult as the diameter of the shaft portion reduces. In order to overcome this difficulty the present invention proposes the arrangements set forth in claims 14 to 23 and in claim 30. An additional problem which arises in cryosurgery is the difficulty of extracting the cryoprobe from the frozen tissue. It will be appreciated that the cryoprobe can only be withdrawn once the bond to the ice-ball has been broken. Release of the cryoprobe from the ice-ball can be achieved by heating the tip. Conventional method involves Joule heating of of bulk resistor placed in the tip and is considered undesirable as the resistor will probably cause artifacts in the image. In order to overcome this difficulty, the present invention proposes the arrangements set forth in claims 24 and 25. Finally, the present invention also relates to a method of monitoring the progress of a cryogenic freezing process comprising use of x-ray computer tomography to visualize phase changes through the associated density changes. I Embodiments of the invention will now be desribed by way of example only and with reference to the drawings which show: Figure 1, a schematic illustration of ' a basic cryo¬ probe unit for cryotherapy, and Figure 2, a longitudinal section through a cryotip. Figure 3, a longitudinal section through an alternativ cryoprobe with provision for heating the shaft portion thereof, Figure 4, a longitudinal section through a further alternative cryoprobe also with provision for heat¬ ing the shaft portion thereof, Figure 5, a longitudinal section through a yet further alternative cryoprobe also with provision for heating the shaft portion thereof, Figure 6, a longitudinal section through another cryoprobe with provision for heating the cryotip, and, Figure 7, a longitudinal section through a cryoprobe similar to that of Figure 6 but with an alternative arrangement for heating the cryotip. Referring firstly to Figure 1, there can be seen a source 1 of a liquefied gas, which can be liquid nitrogen at a pressure of more than 2 atmospheres (and preferably more than 5 atmospheres) a liquefied noble gas or a mixture of a liquefied noble gas with another cryocoolant. Source 1 is connected via a line 2 and an adjustable valve 3 to a flexible hose 4 leading to a cryoprobe 5. In accordance with the invention the liquefied gas is preferably liquefied xenon which, as previously explained, will result in the maximum cooling power in a cryoprobe of the presently described kind. As illustrated schematically in Figure 1, and in more detail in Figure 2, the cryoprobe 5 comprises a shaft portion 6 and a cryotip 7. The shaft portion 6 serves to transfer the liquefied noble gas to the cryotip 7. For this purpose, the shaft portion comprises an inner tube 9 through which the liquefied gas enters the head portion 7. The cryotip 7 consists of a sintered metal body part 11 of a metal of low atomic number Z < 15 and indeed preferably of aluminium. A threaded passage 12 is provided inside the sintered body portion 11 so as to provide a large surface area for the transfer of heat from the sintered body portion to the cryocoolant. It will ' be appreciated that the rate of heat transfer is improved by the large surface area offered by the flanks of the threads 13. At its front end, the body portion 11 converges to a sharp point which facilitates its introduction into body tissue. As previously mentioned, the sintered body portion is enclosed by a thin plated layer 14 of an inert metal which is also easy to sterilize. The inert metal is in this case gold, the large atomic number of gold is not however disadvantageous because the gold layer is very thin in comparison to the sintered body portion. After the liquefied gas or cryocoolant has entered the threaded passage 12 of the body portion 11 a phase change occurs and the gas that is generated is extracted through the coaxial passage 10 defined between the inner tube 9 and the tubular wall structure 8 of the shaft portion. - m - This gas is collected for re-use either through a line running parallel to the flexible hose or through an outer annular passage coaxial to the feed passage through the flexible hose. The maximum diameter of the generally egg-sha'ped head portion 7 is approximately .5 mm, thus generating a cross-sectional area of the order of 2θsquare mm. The shaft portion is of smaller dimensions and preferably has an external diameter such that its cross-section is a maximum of 20 square mm and preferably 10 square mm. The threaded passage 12 will have a major diameter of, at the most, 2 mm and the remaining dimensions will be approximately as shown in the scale drawing of Figure 2. In a particularly preferred arrangement not shown the heat exchanger is formed of a sintered metal such as aluminium (the sintered material has an even lower density than the straight metal), the heat exchanger is coated with a layer of aluminium to form a continuous outer shell which is substantially impermeable and this outer shell is then coated e.g. by plating, with a layer of gold which is substantially inert as far as body fluids are concerned. The outer shell can be formed by electroplating or using other known techniques. The cryotip can of course also be formed in a single piece of metal (plated if necessary). It will be appreciated in all the above embodiments that the tubular wall structure 8 is a conventional vacuum wall structure i.e. comprises tubular inner and outer metalli-c walls separated' by a-yac ' u cavity. Returning now to Figure 3, there can be seen an alternative design of cryoprobe, the length of the shaft has however been considerably shortened for the purpose of illustration In this case the cryotip 5 consists of a piece of solid aluminium which has been turned to provide an annular shoulder 20. This shoulder serves for attachment of the cryotip to the tubular wall structure 8 which, in this case, consists of plastic material, for example polyvinyl- chloride or PTFE.. The tubular wall structure 8 comprises an inner tubular wall member 21 and an outer tubular wall member 22 which are spaced apart by two plastic spacers 23 and 24 at the axial ends of the tubular wall structure. The annular spacers 23 and 24 are secured to the inner and outer tubular members 21 and 22 by adhesive or by a plastic welding technique. The resulting tubular wall structure is secured to the cryotip at the shoulder either by means of adhesive or preferably by means of a fine screw thread (not shown) and a blocking adhesive. The end of the tubular structure remote from the cryotip is embedded in a block of plastic 25 which contains a number of passages and drillings which will now be explained in more detail. As can be seen the inner tube 9 which is preferably a thin-walled aluminium tube includes ' a staggered portion 26 and a straight portion 27 which extends through the plastic block 25 and which provides the inlet connection for the supply of liquid cryocoolant. Immediately above the tubular portion 27 there is illustrated a second metallic thin walled tube 28 which extends parallel to the tube 27 through a passage in the . plastic block 25 and which forms the outlet for the cryocoolant after the latter has passed through the cryotip 5. As is clear from the drawing, the inner and outer tubular wall members are spaced apart by the spacers 23, 24 to define a cavity 29. A cross-drilling 30 passes through the plastic block and through the tubular outer wall member to provide a passage communicating with the cavity 29. A tubular insert 31 extending parallel to the tube portions 27 and 28 breaks into the passage 30, which is plugged at its outer end, and provides an inlet for supplying a heating fluid to the cavity 29. A similar cross-drilling 32 and tubular insert 33 is provided for removing the heating fluid from the cavity 29. The cavity 29 includes two helical coils of plastic strip 34, 35, in the form of a two start thread. These helical strips are so arranged that the heating 'fluid is caused to flow in a first helical path through the cavity 29 to the cryotip and back along a second parallel helical path to the outlet 33. In place of the two helical coils 34 and 35, one can also use two partition walls extending in an axial direction. In practice, a heating fluid for example hot air is supplied to the passage 29 in order to prevent freezing at the outer surface of the tubular wall structure 8. In practice it is generally not necessary to use this heating system until some time after an operation has commenced because it has been found that a considerable time is required for the outer wall surface of the tubular wall structure 8 to reach a temperature at which freezing of the surrounding tissues occurs. In fact, for some applic¬ ations, it may not be necessary to use a heating fluid at all and in this case the cavity can conveniently be filled with a getter for residual gas such as activated carbon, and the tubes 31 and 33 sealed off, possibly after having effected a partial evacuation of the cavity 29. One thus has a type of vacuum insulated structure which further impedes the cooling of the outer surface of the tubular wall structure 8. A similar arrangement to that shown in Figure 3 is illust¬ rated in Figure 4. The same reference numerals will be O PI used in Figure 4 to designate parts which have counterpart in Figure 3. In the arrangement of Figure 4 the cavity 29 is designed to accept a chemical or chemicals which generate heat exothermically. In this case the chemicals, which are preferably two liquids, are injected through the passage 31 using a hypodermic syringe at the start of the operation. The passage 31 is conveniently closed by a removable self-sealing rubber bung 36. The two chemica can be selected so that the exothermic generation of heat takes place at an • increasing rate so that the shaft portion is progressively heated as the operation takes place thus compensating for the otherwise decreasing temperature of the outer surface of the tubular wall structure 8. The second tube 33 can be used to extract the liquids after the reaction so that the cryoprobe can be prepared for re-use. Alternately one chemical can be introduced through the tube 31 and the second chemical through the tube 33 in order to prevent mixing of the two chemicals prior to insertion into the cryoprobe. In a further alternative version of this arrangement the outer wall member 22 consists of a thin metal tube and a single chemical in the form of an acid is introduced into the cavity through the tubular insert 31. The acid is selected to exothermically etch away part of the inside of the tubular wall during the operation thus generating sufficient heat to prevent freezing of the tissue surroundi the shaft portion. A further alternative embodiment in which provision is made for heating the outer surface of the shaft portion 8 is illustrated in Figure 5. Again common reference numera are used to indicate parts which have counterparts in the previous embodiments. In the arrangement of Figure 5, the outer tubular wall member consists of a translucent and preferably transparent plastic which is silvered at its inner surface to make it light reflecting and which MPI is provided with an absorptive outer surface for example by blackening the outer surface. A laser light source 40 is connected to the resulting optical cavity 41 via a plurality of optical fibres 42of which only ' two are shown in Figure 5 for the sake of simplicity. Thermal energy in the form of light generated by the laser 40 is thus introduced into the optical cavity 41 and the light is progressively reflected from the silvered inner surface of the cavity 41 to the blackened outer surface where it is absorbed thus preferentially generating heating at the outer surface. In this embodiment the tubular wall structure again features inner and outer tubular wall members 21 and 22 separated by a small cavity 29. It is however conceivable that this embodiment will work with solely a single tubular member due to the preferential heating of the outer surface. Turning now to Figure 6 there can be seen an alternative design of cryoprobe which has provision for heating the cryotip after completion of the freezing phase so as to melt a layer of water around the tip and to facilitate its withdrawal from the patient. In this embodiment a source of heated gas, for example hot air, can be connected via a valve 44, to the tubular insert 28 normally used for removal of the cryocoolant from the cryoprobe. In this case the tube 9 acts as the outlet for the heating fluid. Clearly suitable valves are required in the inlet and outlet flow lines to enable the surgeon to select heating or cooling as required. In an alternative arrange¬ ment, Fig. 7 " a laser light source 45 may be used to heat the cryotip. For this purpose a light guide, for example in the form of a fibre or a bundle of optical fibres, extend from the laser through the tubular insert 28, or through a second specially provided tubular insert (not shown). Light from the laser is directed towards the cryotip which may be provided with a blackened surface 47 so that it is strongly absorbent. If the arrangement of Figure 7 is used with an arrangement similar to Figure 5, then the laser light source 40 can be used in place of the laser light source 45. In all the embodiments of Figures 3 through 7 the cryotip is only schematically illustrated and it'will be appreciate that the tip can, if desired, be made larger than the shaft and can, optionally, be constructed in the same manner as the cryotip of Figure 2. It will be appreciated by the person averagely skilled in the art that x-ray computer tomography can readily be used to monitor the development of the ice ball during use of any of the above-described cryoprobes for deep in-body surgery without the presence of the cryoprobe causing artefacts which confuse the radiographic image.

Claims: ; t_ at * ι «τrt s 1. A cryoprobe comprising a shaft portion and a cryotip wherein at least the cryotip consists of a material or mat¬ erials of low atomic number, Z ,15. 2. A cryoprobe in accordance with claim 1, wherein said material is a metal. 3. A cryoprobe in accordance with either of the preceding claims / wherein the material consists of an element of the group comprising Li, Be, Mg, and aluminium, or an alloy of any of these elements, either with themselves or with other elements. 4. A cryoprobe in accordance with either of the preceding claims, wherein the head portion consists of an inner heat exchanger and a thin outer shell. * 5. A cryoprobe in accordance with claim 4, wherein the heat exchanger consists of a sintered metal. 6. A cryoprobe in accordance with either of claims 4 or 5, wherein the shell is made of aluminium or another metal of low atomic number. 7. A cryoprobe in accordance with any one of claims 4 to 6, wherein said outer shell is covered with a layer of noble metal, copper or chromium having a thickness less than 0.5 mm and preferably less than 0.2 mm. 8. A cryoprobe in accordance with claim 7, and wherein said layer is applied by plating. 9. A cryoprobe in accordance with any one of the preceding claims, wherein the shaft portion has a smaller cross- section than the cryotip. OMPI 10. A cryoprobe in accordance with claim 9, wherein the cryotip has a cross-sectional area smaller than 20 square mms and preferably less than 10square mms. 11. A cryoprobe in accordance with either of claims 9 or 10, wherein the shaft portion has a cross-sectional area below 20 square mms, preferably below 10 square mms. 12. A cryoprobe in accordance with any one of the preceding claims, wherein said head portion is substantially egg-shaped. 13. A cryoprobe in accordance with any one of the preceding claims, wherein said head portion is provided with a sharp point at its front end. 14. A cryoprobe in accordance with any one of the preceding claims wherein the shaft portion comprises an inner tube positioned within a tubular wall structure, said tubular wall structure having substantially concentrically disposed inner and outer tubular wall members. 15. A cryoprobe in accordance with claim 14 wherein said inner and outer tubular wall members are spaced apart by a cavity. 16. A cryoprobe in accordance with claim 15 wherein said cavity contains a getter for gas such as activated carbon. 17. A cryoprobe in accordance with claim 15 wherein means are provided for supplying a heating fluid to said cavity at an inlet ead thereof remote from said cryotip,wherein means are provided in said cavity for causing said heating fluid to flow along said cavity to said cryotip and back to said inlet end and wherein means are provided at said inlet end for removing said heating fluid from said cavity. OMPI 18. A cryoprobe in accordance with claim 17 wherein said means for causing said heating fluid to flow along said cavity comprises a helical structure or tube disposed within said cavity. 19. A cryoprobe in accordance with claim 17 and wherein said means for causing said heating fluid to flow along said cavity comprises partition wall means extending along said • cavity to said cryotip. 20. A cryoprobe in accordance with claim 16 wherein means is provided for introducing a chemical or chemicals into said cavity to generate heat exother m-ically. 21. A cryoprobe in accordance with claim 1 or claim 14 wherein the outer tubular wall member comprises a translucent material and has a reflective internal surface and an ab- sortive outer surface and wherein means is provided for introducing light energy into said outer tubular wall member. 22. A cryoprobe in accordance with claim 21 wherein said means for introducing light energy into said outer ubular wall member comprises a fibre optical system. 23. A cryoprobe in accordance with any one of the claims 14 to 22 wherein said inner and -outer tubular members are of synthetic material. 24. A cryoprobe in accordance with claim 1 or claim 14 and wherein means are provided for supplying a heaiing fluid to said cryotip via either said inner tube or via the space between the inner tube and the tubular wall structure. 25. A cryoprobe in accordance with claim 1 or claim 14 wherein means is provided for directing laser light through said inner tube or through the space between the inner tube and the tubular wa ' ll structure to said cryotip to heat the same 26. A cryoprobe, in particular in accordance with one of the preceding claims, wherein the coolant comprises one of liquefied nitrogen at a pressure greater than'two atmospheres, a liquefied noble gas, or a mixture of a liquefied noble gas with another cryocoolant. 27. A cryoprobe in accordance with claim 26, wherein the liquefied noble gas is helium kept in superfluid state, i.e. below 2.15 K. 28. A cryoprobe in accordance with claim 26, wherein the liquefied noble gas is krypton or xenon or a mixture thereof. 29. A method of monitoring the progress of a cryogenic freezing process comprising the use of x-ray computer tomography to visualize phase changes through the associated density changes. 30. A cryoprobe in. accordance with any one of the preceding claims 14, 15 and 26 to 28 wherein the shaft potion of the cryoprobe is heated by means of Joule heating using a ' resistor distributed along the shaft length and of radial thickness less than 1 mm, said resistor preferably being located on the inside surface of the outer tubular wall member.

Inventors: DRUKIER ANDRZEJ KAMIL, DRUKIER, ANDRZEJ, KAMIL
Applicants: DRUKIER ANDRZEJ KAMIL, DRUKIER, ANDRZEJ, KAMIL
Application year: 1983
Main classification: A61B17
IPC codes: A61B18, A61B19